NJ jury awards $13.2 million to family of nursing home rehab patient who died

Share this article:

A nursing home negligence case in New Jersey ended last week with a $13.2 million award to a former resident's family, lawyers have announced.

The case involved Mary Dwyer, who was admitted to the Alaris Health at Harborview facility in Jersey City for short-term rehabilitation after falling at home and dislocating a shoulder, according to plaintiffs' law firm Stark & Stark. Over the course of about three months, the 87-year-old Dwyer developed large Stage IV ulcers, lost 20 pounds, underwent nine wound debridements, two bone shavings and a colostomy — conditions and treatments that attorneys said were “unnecessary and preventable.” She died on Feb. 27, 2010.

“With adequate staffing and a properly run facility she would have completed her rehab and gone back home,” reads a statement from Stark & Stark. “Instead, she died an undignified death in pain.”

The 180-bed, for-profit facility vigorously denies the charges, calling them “false” and erroneous” in a statement. It also noted that the facility "recently received" a 5-star quality measures rating from the government. Harborview intends to appeal the verdict, which it describes as a “gross miscarriage of justice.”

Hundreds of Haborview workers went on strike for three days in 2010 to protest low wages, according to The Jersey Journal.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.